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Abstract
Purpose Myocardial perfusion imaging (MPI) has limitations
in the presence of balanced multivessel disease (MVD) and
left main (LM) coronary artery disease, occasionally resulting
in false-normal results despite the high cardiovascular risk
associated with this condition. The purpose of this study was
to assess the incidence of severe coronary artery disease
(CAD) in the presence of a very high Agatston coronary artery
calcium (CAC) score (>1,000) in stable symptomatic patients
without known CAD but with normal MPI results.
Methods A total of 2,659 prospectively acquired consecutive
patients were referred for MPI and evaluation of CAC score
by CT. Of this patient population, 8 % (222/2,659) had ische-
mia without myocardial infarction (MI) on MPIand 11 %
(298/2,659) had abnormal MPI (MI and/or ischemia). On pre-
sentation 1 % of the patients (26/2,659) were symptomatic,
had a CAC score >1,000 and normal MPI results. The defini-
tion of normal MPI was strict and included a normal hemo-
dynamic response without ischemic ECG changes and normal
imaging, particularly absence of transient ischemic dilation.
All of these 26 patients with a CAC score >1,000 and normal
MPI findings underwent cardiac catheterization.
Results Of these 26 patients, 58 % (15/26) had severe disease
(≥70 % stenosis) leading to revascularization. Of this group,
47 % (7/15) underwent percutaneous intervention, and 53 %
(8/15) underwent coronary artery bypass grafting. All of these
15 patients had either MVD (14/15) or LM coronary artery
disease (1/15), and represented 0.6% (15/2,659) of all referred
patients (95 % CI 0.3 – 0.9 %). The majority, 90 % (8/9), had
severe CAD with typical chest pain.
Conclusion A very high CAC score (>1,000) with normal
MPI in a small subset of symptomatically stable patients was
associated with a moderate incidence of severe CAD (95%CI
37 – 77 %). Larger studies and/or a meta-analysis of small
studies are needed to more precisely estimate the incidence
of CAD in this population. This study also supports the con-
cept that a normalMPI result in patients with severe CADmay
be due to balanced MVD.
Keywords CTcoronary artery calcium score . Myocardial
perfusion imaging . Sestamibi
Introduction
Patients with normal myocardial perfusion imaging (MPI) re-
sults on SPECT have a very low cardiac event rate estimated
at <1 % per year [1–3]. Although rare, left main (LM) coro-
nary artery disease, and balanced multivessel disease (MVD)
can result in a falsely normal MPI study despite the high
associated cardiovascular risk [4, 5]. Only a fraction of pa-
tients with coronary artery disease (CAD) involving the LM
artery or MVD have perfusion abnormalities in all the coro-
nary artery territories on MPI [6]. Clinical information,
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exercise data and other stress parameters provide important
additional information to identify these patients [4, 7–12].
Atherosclerosis may be associated with calcium de-
position in the coronary arteries [13]. Coronary calcifi-
cation can be quantified on CT using the Agatston cor-
onary artery calcium (CAC) score (see the CAC
bibliography, that includes reviews, in Appendix 1 of
the Electronic supplementary material). CAC scoring
has been used in asymptomatic individuals to diagnose ath-
erosclerosis and to predict future cardiac events, i.e., to deter-
mine the long-term 10-year mortality rate beyond the Fra-
mingham risk score. High CAC scores are associated with a
greater degree of stenosis and ischemia. The distribution of
CAC scores in patients with normal MPI is wide.
Our hypothesis was that a very high CAC score of >1,000
with normal MPI, in the absence of high-risk markers, partic-




We prospectively evaluated 2,659 consecutive patients, re-
ferred by internists and cardiologists for clinical reasons, for
a hybrid study involving both MPI and CAC scoring between
January 2007 and July 2011 (Fig. 1).
Our study was approved by our local university ethics
board. All patients signed written informed consent to be
entered into a registry and be followed clinically. The
consent did not include an invasive coronary angiography
(ICA). The patients completed a written cardiac question-
naire and were interviewed by a cardiology nurse and a
nuclear cardiology physician. Historical evaluation includ-
ed: previous cardiac testing, procedures, and consultation
reports which were reviewed by a Nuclear Medicine fel-
low and a Cardiology fellow. The characteristics of the 2,
659 patients referred are presented in detail in Appendix 2
of the Electronic supplementary material.
We found 26 patients without known CAD with normal
MPI and a CAC score of >1,000 and without high-risk param-
eters, particularly absence of transient TID. High risk param-
eters did not include the CAC score, an independent variable.
The demographics of the 26 patients with normal MPI and a
CAC score of >1,000 are shown in Table 1. The pretest prob-
ability of CAD was determined using the model of Diamond
et al. [14].
Physician-supervised maximum-workload symptom-limit-
ed exercise [15] was performed if possible, with or without
pharmacological vasodilation. Target heart rate was not a cri-
terion for stopping exercise.
Myocardial imaging
For details of the technique see Appendix 3 of the Electronic
supplementary material (Myocardial Imaging Technique) which
follow the American Society of Nuclear Cardiology guidelines
[16]. The definition of normalMPI was strict (Appendix 4 of the
Electronic supplementary material: Definition of a Normal MPI
[17–21]). In summary, normalMPI included normal imageswith
normal hemodynamic response and without ischemia on ECG,
and absence of TID (the normal TID ratio is <1.20).
Coronary calcium score
The Agatston CAC scores were obtained on a GE LightSpeed
VCT 64-detector CT scanner within 1 week of the stress MPI
study and analyzed using an AW 4.4 workstation [22]. A very
high CAC score was defined as >1,000. This value has been
used in multiple studies to define a very high CAC score in
asymptomatic individuals to predict future cardiac events be-
yond the Framingham risk score [2, 22, 23]. CAC scores were
acquired and analyzed by one experienced technologist using
prospective ECG gating, a 2.5-mm slice thickness, 120 kV tube
voltage, 200 mAs tube current per rotation, and a large field-of-
2,659 patients referred for MPI 
and CAC score
2,361 patients with 
normal MPI
298 patients with 
abnormal MPI
2,335 patients with 
normal MPI and CAC 
score < 1,000
26 patients with 
normal MPI and CAC 
score > 1,000
15 patients with 
normal MPI, and CAC 
score >1,000 and 
severe CAD 
11 patients with normal 
MPI, and CAC score 
>1,000  and without 
severe CAD
9 patients with 3-
vessel disease on 
cardiac 
catheterization
6 patients with 2- vessel 
disease    (1 patient with 
LM) on cardiac 
catheterization
Fig. 1 Flow chart of patient enrollment. MPI myocardial perfusion
imaging, CAC score Agatston coronary artery calcium score, CAD
coronary artery disease, LM left main coronary artery disease
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view of 50×50 cm. The CAC score was calculated with com-
mercially available software (Smartscore, GE Healthcare) [21].
Coronary angiography
We prospectively encouraged these symptomatic patients with
normal MPI and a very high CAC score of >1,000 to undergo
ICA, as our hypothesis was that a clinically significant inci-
dence of severe CAD would be present in this population. All
26 patients underwent ICA. Avisual grading system was used
to assess the severity of lesions in all major coronary arteries.
Stenosis was defined as: no stenosis (0 – 24 %), mild
(25 – 49 %), moderate (50 – 69 %) and severe 70 – 100 %),
except for LM coronary artery disease where moderate steno-
sis was 25 – 49 % and severe stenosis was 50 % or greater
[24]. Catheterization was performed using Siemens Axiom
Artis equipment. The scoring system reflects the most severe
stenosis in each major vessel, i.e. the LM coronary artery (we
assigned to two-vessel disease), the left anterior descending
coronary artery, the left circumflex coronary artery, and the
right coronary artery, or their major branch vessels >1.5mm in
diameter). The intermediate ramus branch was defined as a
branch of the left anterior descending coronary artery by
convention.
Statistical methods
Statistical analysis was performed with commercially
available software (SPSS version 16.0), and confirmed
with previously available RS/1 software (BBN technol-
ogies). Categorical variables are presented as frequen-
cies and continuous variables as means±SD for normal
distributions and medians±interquartile ranges (IQRs)
for skewed distributions. Variables were compared with
Fisher’s exact test for categorical variables and by Stu-
dent‘s unpaired t test for continuous variables, unless
otherwise specified. Two-tailed P values <0.05 were
considered statistically significant.
Results
Demographics of patients with CAC score >1,000
and normal MPI
The demographics of the 26 symptomatic patients without
known CAD with normal MPI results and a CAC score of
>1,000 are shown in Table 1.
Table 1 Demographics of the 26








Male 17 (65 %) 10 (38 %) 7 (27 %)
Age (years)
Mean±SD 68±10 70±10 65±10
Range 40 – 81 53 – 81 40 – 74
Hypertension 18 (69 %) 9 (35 %) 9 (35 %)
Diabetes 5 (19 %) 2 (8 %) 3 (12 %)
Dyslipidemia 13 (50 %) 8 (31 %) 5 (19 %)
Family history 6 (23 %) 5 (19 %) 1 (4 %)
Smoking 7 (27 %) 3 (12 %) 4 (15 %)
Pretest probability of CAD
Low 2 (8 %) 1 (4 %) 1 (4 %)
Intermediate 15 (58 %) 6 (23 %) 9 (35 %)
High 9 (35 %) 8 (31 %) 1 (4 %)
Reasons for referral
Chest pain 19 (73 %)
Typical 9 (35 %) 8 (31 %) 1 (4 %)
Atypical 10 (38 %) 4 (15 %) 6 (23 %)
Chest pain and/or (subjective
or objective) dyspnea
4 (15 %) 3 (12 %) 1 (4 %)
Preoperative assessment with chest pain 2 (8 %) 0 2 (8 %)
LBBB with atypical chest pain 1 (4 %) 0 1 (4 %)
Values are number (%) of patients, except age in years
CAD coronary artery disease, LBBB left bundle branch block
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CAC scores
The mean CAC score in the 26 patients was 2,131 (range 1,
104 – 5,194). The mean CAC score in the 15 patients with severe
CAD was 2,229 (range 1,106 – 5,194), and the mean CAC score
in the 11 patients without severe CADwas 2,093 (range 1,104 – 3,
585; P=0.58, not significant). Thus the CAC scores were similar.
Left ventricular ejection fraction
The median left ventricular ejection fraction (LVEF) in the 15
patients with severe CAD (≥70 % stenosis) was 65 % (IQR
5 %), and the median LVEF in the 11 patients without severe
CAD was also 65 % (IQR 5 %; P=0.99, not significant).
Coronary angiography
Table 2 shows the ICA results in all 26 patients including 9
patients with normal coronary arteries or mild CAD and 17
patients with moderate to severe CAD. Of the 17 patients with
moderate to severe CAD, approximately two-thirds (ten pa-
tients, nine with severe CAD) had three-vessel disease, ap-
proximately one-third (six patients, all with severe CAD)
had two-vessel disease (LM coronary artery disease was cat-
egorized as two-vessel disease), and one patient with moder-
ate CAD had single-vessel disease. Thus 15 patients (58 %)
had severe CAD (≥70 % stenosis). None of the patients with
severe CAD (n=15) had single-vessel disease, 6 (40 %) had
two-vessel disease and 9 (60 %) had three-vessel disease.
Percutaneous coronary intervention/coronary artery
bypass grafting
Of the 15 patients with severe CAD, 7 (47%) underwent stenting
and 8 (54 %) underwent coronary artery bypass grafting.
Number of CAD risk factors
The patients with and without severe stenosis had, on average,
two CAD risk factors. The number of CAD risk factors in 15
patients with severe CAD was 1.8±1.3 and in 11 patients
without severe CAD was 2.0±1.2 (P=0.69, not significant).
Typical chest pain
Of the 26 patients, 17 had atypical chest pain and 9 had typical
chest pain. As shown in Table 3, typical chest pain occurred in
8 of the 15 patients with severe CAD and was significantly
more frequent in those with than in those without severe CAD
(P=0.04) being present in only 1 (9 %) of the 11 patients
without severe CAD. Thus the incidence of severe CAD was
90 % (8 of 9 patients) among those with typical chest pain
with a normal MPI result and CAC score >1,000.
Stress testing
Pharmacological vasodilator stress alone was performed in the
minority of patients (Table 4). Only 1 of the 15 patients with a
falsely normalMPI result and severe obstructive CAD (≥70%
stenosis) underwent pharmacological vasodilator stress with-
out supplementary exercise.
Index case
A 79-year-old man (178 cm, 85 kg) had typical chest pain,
hypertension and dyslipidemia. Two-day MPI was performed
using half-time acquisition. Dipyridamole plus gentle cycling
(50 W) was used for stress, with 1,000 MBq of sestamibi for
rest and stress imaging and iterative reconstruction with atten-
uation correction and depth resolution recovery (Fig. 2). This
showed homogeneous perfusion with questionable TID visu-
ally. The left ventricle did not appear larger after stress, either
visually (not shown) or quantitatively using filtered back pro-
jection reconstruction (TID 1.15; normal <1.20). The CAC
score was 4,024 (Fig. 3). ICA showed a severe stenosis in
the left main coronary artery distally with poststenotic dilation
(aneurysm formation; Fig. 4).
Table 2 Coronary angiography
results in all 26 patients Moderate–severe CAD (N=17, 65 %) Normal–mild CAD (N=9, 35 %)
Normal – 1 (11 %)
Mild (<50 % stenosis) – 8 (90 %)
Moderate (50 – 69 % stenosis) 2 (12 %) –
Severe (≥70 % stenosis) 15 (88 %) –
Normal vessels – 1 (11 %)
Single-vessel disease 1 (6 %) 1 (11 %)
Two-vessel disease 6 (35 %) 3 (33 %)
Three-vessel disease 10 (59 %) 4 (44 %)
CAD coronary artery disease
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Discussion
Our study showed a moderate incidence of severe obstructive
multivessel CAD in all 26 symptomatic patients without
known CAD with a normal MPI result and a CAC score of
>1,000. All underwent ICA. The other patients with normal
MPI who had a CAC score<1,000 are shown in Appendix 5
of the Electronic supplementary material. This group appeared
to have a lower pretest probability of CAD as expected as shown
in in Appendix 6 of the Electronic supplementary material. Is-
chemia is more closely related to the absolute CAC score than
CAC percentile scores adjusted for age, ethnicity, and gender
[25], as is prognosis. We used an absolute CAC score.
False-negative MPI studies in patients with LM coronary
artery disease and/or MVD is a limitation of MPI. In one
study, without accounting for high-risk nonperfusion vari-
ables, LM coronary artery disease and/or MVD were missed
in 17 % of patients with normal MPI [4]. The disease was not
missed in any patient when high-risk variables were consid-
ered, particularly TID. Many of these patients (45 %, 45/101)
underwent exercise stress testing alone. In another study, 58
consecutive patients with a normal MPI result underwent ICA
[5]. Of these 58 patients, 18 had 30 stenoses (>50 % stenosis).
Logistic regression analysis revealed typical angina to have
the strongest association. Typical angina in patients referred
for noninvasive imaging has recently been shown [26, 27] to
have a lower predictive value than originally proposed by
Diamond et al. [14]. The work of Diamond et al. was based
on patients interviewed by a cardiologist, and was not based
on self-administered cardiac questionnaires, and all the pa-
tients underwent ICA. In our study, 90 % of the patients (eight
of nine) with typical chest pain, a CAC score >1,000, and
normal MPI, had severe CAD (stenosis ≥70 %). By combin-
ing high-risk nonperfusion variables, particularly TID, clinical
variables, particularly typical angina, and a very high CAC
score, the likelihood of false-negative MPI studies may be
reduced.
Our study expands the limited literature (two papers) an-
giographically demonstrating CAD in patients with normal
MPI, and a high CAC score [28, 29]. Choudhary et al. [28]
examined a small number of patients (n=84) with normalMPI
and a high CAC score. CADwas documented on coronary CT
angiography (CCTA), but not on ICA. The rate of abnormal-
ities among our patients was low, although greater than among
the patients in the study by Choudhary et al. In our study, 11%
of patients (298/2,659) had an abnormal MPI result. In the
study by Choudhary et al., 4 % of patients (3/84) had an
MPI abnormality (less robust). Choudhary et al. chose a lower
CAC score of >400. The other study of false-negative MPI
results in patients with a very high CAC score of >1,000 was
by Ghadri et al. [29] whose patients underwent ICA. Single-
vessel disease was more prevalent in the study by Ghadri et al.
being seen in 41 % [15/29] of patients with a false-negative
MPI result and a CAC score >1,000, whereas none of our
patients, who had more severe stenosis (≥70 %) and normal
MPI, had single-vessel disease. The studies by Ghadri et al.
and Choudhary et al. differ from our study in that stenosis was
defined visually as 50% or greater, whereas we chose 70% or
greater, except in LM coronary artery disease where we chose
50 % or greater. The false-negative rate found by Choudhary
et al. and Ghadri et al. might have been related to the lack of
exercise with vasodilator pharmacological stress. Choudhary
et al. used dipyridamole in some of their patients, without
exercise. Ghadri et al. used , Rozanski et al. [31] assessed
the frequency of cardiac death and myocardial infarction over
a mean follow-up of 32±16 months in 1,153 patients under-
going both CAC scanning andMPI. Of these patients, 140 (28
ischemic, 112 nonischemic) had a CAC score>1,000. The
authors excluded revascularized patients (10 of the 112
nonischemic patients underwent early revascularization at
<60 days or late revascularization at >60 days), in contrast
to our study in which such patients were included. They sug-
gested that high CAC scores do not confer an increased risk of
cardiac events. The excluded group of patients who
underwent revascularization (9 % of non-ischemic patients)
might have been at greater risk of cardiac death/myocardial
infarction events. The true number of patients with severe
Table 3 Typical chest pain
Yes No
Patients with severe CAD (n=15) 8 (53 %)* 7 (47 %)
Patients without severe CAD (n=11) 1 (9 %) 10 (91 %)
*P=0.04 with severe CAD and typical chest pain
Severe CAD: ≥70 % stenosis




With severe CAD (n=15) 13 (87 %; cycling 11, treadmill 2) 1 (7 %) 1 (7 %)
Without severe CAD (n=11) 7 (64 %; cycling 6, treadmill 1) 1 (9 %) 3 (27 %)
P=0.40, not significant (Freeman-Halton extension of the Fisher’s Exact test)
Exercise was maximum workload symptom-limited, plus pharmacological vasodilator stress if needed
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CAD could be greater as not all patients with a CAC score >1,
000 underwent ICA. This is partial verification bias. Follow-
up with at least 80 % success only occurred for 2 years (50 %
follow-up at 3 years). Therefore, prognosis assessment was
short-term.
Study strengths
All patients in our study completed a self-administered cardiac
questionnaire and were interviewed by a cardiology nurse and
a nuclear cardiologist. Data were recorded using a
Fig. 2 Two-day (rest/stress) MPI
study using half dose in a patient





(stress images above and
corresponding rest images below)
do not show a perfusion defect.
The images without attenuation
correction (not shown) had a
normal transient dilation ratio of
1.15 (normal <1.20). Attenuation
artifacts disappeared with
attenuation correction. These
attenuation corrected images with
depth resolution recovery show
possible transient dilation ratio
visually. Normal range for
transient dilation ratio with
attenuation correction is not
known
Fig. 3 Dense coronary artery calcification in the left main coronary
artery (LM) distally and in the left anterior descending coronary artery
(LAD). The coronary artery calcium score was 4,024. Arrows indicate the
mid-LM coronary artery and the proximal LAD coronary artery
Fig. 4 Selective coronary angiogram with catheter in the left main
coronary artery (LM). Severe stenosis with tapering of the left main
coronary artery distally and with poststenotic dilation (aneurysm) are
seen. Arrows indicate the mid-LM coronary artery and tight stenosis of
the LM coronary artery distally
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predesigned form specifically designed to support a research
database. The large-scale CAC score studies obtained patient
information solely from patient-completed cardiac question-
naires [2, 26]. By performing MPI and assessing CAC simul-
taneously, we reduced a source of referral bias to CAC scoring
[32]. Maximum-workload symptom-limited exercise was per-
formed whenever possible in addition to pharmacological
stress. All patients had ICA. This eliminated partial verifica-
tion bias (posttest referral bias). The Bgold standard^ in our
study was ICA, not CCTA. Multiple studies by highly expe-
rienced readers at respected academic institutions have shown
lower diagnostic accuracy of 64-slice CCTA compared with
ICA, particularly in patients with CAC scores above 400
[33–36]. CCTA often requires aggressive pretreatment with
beta blockers to achieve diagnostic quality images whereas
ICA does not.
Study limitations
Our study had a limited selection of physician-referred pa-
tients, as do all single-center studies. Dyspnea was entered
into the database, whether subjective or objective, whether
expected (e.g. pulmonary disease) or due to other disease, or
due to advanced age, deconditioning or unexpected disease
(possible angina equivalence). Thus, the incidence of dyspnea
was high in our referred population. We investigated a very
small subgroup. This subgroup would have been larger if our
selection criteria had been broader (we strictly defined
Bnormal^ MPI to avoid the possibility of including patients
with any abnormality or possible abnormality). However, we
wanted to determine the incremental value of one variable. We
used visual assessment of the degree of stenosis on ICA. We
did not use functional flow reserve (FFR) [37]. A coronary
stenosis apparent visually may not be hemodynamically
significant.
Comparison of the severity of coronary artery stenosis on
ICA and functional severity as assessed using FFR showed
that 35 % of 50 – 70 % stenoses and 80 % of 71 – 90 %
stenoses were functionally significant and almost all substan-
tially occluded arteries (96%)were significantly affected [37];
clearly stenosis of 70 % or greater correlates better with func-
tional assessment than stenosis of 50 % or greater. The lack of
FFR assessment in our study would probably have had no
effect as 15 of 26 patients (58 %) had severe disease, and only
2 patients (7 %) with moderate disease might have benefited
from FFR.
We used SPECT MPI rather than quantitative PET; the
latter is better at detecting balanced disease [9]. Quantitative
three-dimensional myocardial blood flow imaging with PET
is not as available as SPECT. The incidence of false-negative
MPI results could have been greater in our 2,659 patients than
we have reported, since we only examined patients with a
CAC score of >1,000. Dyspnea was noted in 37 % (973/2,
659) of our referred patients. Dyspnea includes subjective
(patient declared) and physician determined objective dyspnea
not explained by pulmonary disease (angina equivalence).
Clinical applicability, generalizability and clinical
relevance
CT attenuation-corrected MPI requires an emission and a
transmission scan. A single transmission scan can be used
for CT attenuation correction of the rest and stress MPI emis-
sion scans. The CAC score can be used for CT attenuation
correction of SPECT and PET images [38]. Thus, the CAC
score can be obtained without another transmission scan ac-
quisition. There are vendors currently offering traditional so-
dium iodide crystal/photomultiplier tube Anger systems with
an integrated multislice diagnostic CT scanner, e.g. a six-slice
CT scanner. The newer solid-state cadmium-zinc-telluride
(CZT) gamma cameras may not have integrated attenuation
correction capability. Currently a 64-slice CT system integrat-
ed with a CZT camera is commercially available. CZT MPI
studies without an integrated diagnostic CT scanner require a
separate acquisition for a transmission map either using a low-
end CT scanner, not capable of obtaining a CAC score, or
using a separate stand-alone CT scanner capable of obtaining
a CAC score.
The importance of perfusion versus anatomy (CCTA/ICA)
in risk stratification is under investigation. MPI currently re-
mains an important widely available method for risk stratifi-
cation, particularly in older patients. TID is lauded as a clini-
cally useful marker of severe CAD [20]. This was based on
treadmill exercise MPI without attenuation correction with
greater than 85 % heart rate. However, two recent studies in
which stress was not limited to adequate treadmill exercise
demonstrated low yield and nonspecifically of TID [39, 40].
Another recent study has also shown that attenuation correc-
tion can increase TID to abnormal levels [26]. ThusMPI, even
with attenuation correction, can miss balanced CAD.
Temporal stability of results
In our referred population, interim analysis half-way into
the study showed the same incidence of severe CAD in
patients with a CAC score >1,000 and normal MPI (6 of
14 patients); the final combined proportion of patients with
severe CAD was 15 of 26. Thus, among our patients with
normal MPI and a CAC score >1,000, there was temporal
stability in the proportion who had severe obstructive CAD.
The confidence interval for the proportion of patients
(57.7 %, 15 of 26) with severe CAD, normal MPI and
CAC score>1,000 was 36.9 – 76.7 %. Larger studies
and/or a meta-analysis of small studies are needed to more
precisely estimate the CAD incidence in this population.
However, this is the current best estimate.
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Cost effectiveness and clinical utility of a hybrid CAC
score plus MPI study
MPI is well known to be cost effective, for example in reduc-
ing the number of cardiac catheterizations. A CAC score prior
to MPI has recently been suggested to allow selection of pa-
tients at higher risk of ischemia [41] and may lead to fewer
normal MPI examinations. However, it is known that a zero
CAC score alone cannot rule out obstructive noncalcified
CAD [42, 43]. The cost effectiveness and clinical utility of a
routine hybrid CAC score plus MPI study needs to be
determined.
Conclusion
We prospectively determined the incidence of severe CAD in
living patients with a very high CAC score and normal MPI in
contrast to previous long-term retrospective studies investigat-
ing 10-year all-cause mortality. In symptomatic patients with-
out known CAD a very high CAC score (>1,000) with a
normal MPI result (high-risk stress markers, particularly
TID, absent) was associated with an intermediate probability
of severe CAD, typically requiring revascularization.
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